Knight Therapeutics Inc (TSE:GUD) is scheduled to be releasing its earnings data before the market opens on Thursday, November 9th. Analysts expect Knight Therapeutics to post earnings of C$0.03 per share for the quarter.

ILLEGAL ACTIVITY NOTICE: “Knight Therapeutics Inc (GUD) Scheduled to Post Earnings on Thursday” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/11/03/knight-therapeutics-inc-gud-scheduled-to-post-earnings-on-thursday.html.

Separately, National Bank Financial cut their price objective on shares of Knight Therapeutics from C$11.75 to C$10.75 in a research report on Friday, August 11th. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of C$10.86.

Knight Therapeutics Company Profile

Knight Therapeutics Inc is a Canada-based pharmaceutical company. The Company is engaged in developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products, consumer health products and medical devices in Canada and select international markets. It finances other life sciences companies in Canada and internationally.

Receive News & Ratings for Knight Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knight Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.